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Factors associated with skin and soft tissue infections among people who 
inject drugs in the United Kingdom: a comparative examination of data 
from two surveys.  
ABSTRACT 
Background 
People who inject drugs (PWID) are at high risk of injection-related skin and soft tissue 
infections (SSTI). If not treated promptly, these can lead to serious health complications, 
which are a considerable healthcare burden. Data from two community surveys, with 
different approaches, were used to assess SSTI prevalence and associated factors among 
PWID to inform intervention implementation. 
Methods 
Data were analysed from two surveys, a national surveillance survey (n=2,874; 2017-18) of 
infections among PWID in the United Kingdom (UK) and an in-depth survey (n=455; 2018-
19) of SSTI among PWID based in London, UK. Multivariable logistic regression models
were constructed to ascertain the factors associated with self-reported SSTI.  
Results 
High prevalence of SSTI were reported in both samples: 52% of participants from the 
national surveillance survey reported having SSTI within the preceding 12 months and 65% 
of the London sample reported a lifetime history of SSTI. The factors associated with SSTI in 
both surveys were similar, including older age; number of years injecting; number of 
attempts required to inject into the vein; injecting into the hands, feet, groin or neck and re-
using or sharing needles/syringes. 
Conclusions 
The number of PWID reporting SSTI in the UK is concerningly high. The two surveys used 
different recruitment approaches but found similar associations. We provide strong evidence 
of a relationship between venous access difficulty and SSTI. To stem the increase of SSTI 
and related complications in the UK, it is crucial that interventions attend to the underlying 
causes of venous damage among PWID.  
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1. INTRODUCTION:  
People who inject drugs (PWID) constitute an extremely vulnerable population with high 
levels of morbidity and premature mortality. Skin and soft tissue infections (SSTI) 
disproportionally affect PWID with global lifetime prevalence estimates ranging from 6% in 
Australia, through 27% in the USA to 69% in Ireland (Larney et al., 2017; Maloney, 2010; 
Salmon, 2009). They are also a common factor leading to hospitalisation, for example, a 
study found SSTI accounted for 64% of infections among PWID admitted to a hospital in 
Miami, USA (Tookes et al., 2015). Despite the high global prevalence of SSTI, public health 
policy and associated harm reduction interventions for PWID have largely focused on 
preventing overdoses, and on the prevention and treatment of blood borne viruses (Boucher 
et al., 2017), with elimination targets in place for viral hepatitis and HIV (UNAIDS, 2017; 
World Health Organisation, 2016). The development of associated prevention and treatment 
interventions have been comparatively neglected.  
 
Bacterial SSTI in PWID have been increasing in the UK since 2012/13, with yearly increases 
in hospital admission data reported, especially in those aged 45-55 years old (18% increase in 
admissions per year) (Lewer et al., 2017). Laboratory surveillance of methicillin-sensitive 
and methicillin-resistant Staphylococcus aureus (MSSA/MRSA) and Group A streptococci 
(GAS), common bacteria found in SSTI, has also shown a spike in infections (Public Health 
England, 2019a). Several outbreaks of GAS and MRSA have been reported in England, with 
a large number of cases reported in prisons, among the street homeless and/or PWID (Bundle 
et al., 2017; Kwiatkowska et al., 2018; Packer et al., 2019; Public Health England, 2019a). 
The cause of the recent increase in SSTI is not clear but is likely to be multifactorial, with 
possible factors including an aging cohort of PWID, the impact of austerity on services, 
increased homelessness, and changes in drug use (Harris et al., 2020; Public Health England, 
2019a) 
 
Bacterial SSTI in PWID are most commonly found on the arms, legs, buttocks or groin, 
corresponding to common drug injection sites (Hope et al., 2008). SSTI are often 
characterised by the presence of pus (specific to abscesses) or tenderness, swelling and 
redness (cellulitis). In addition, poor vein health as a consequence of injecting drug use can 
lead to chronic ulceration, particularly on the legs, which significantly impact on PWID 
mobility and quality of life (Hope, 2010). PWID experience multiple barriers to care access, 




stigma (Miller Lloyd et al., 2020; Neale et al., 2008), with many self-treating their infections 
and/or delaying treatment seeking (Gilbert et al., 2019; Roose, 2009). This can result in 
increased disease severity and prolonged inpatient hospitalisation (Gilbert et al., 2019). 
Complications associated with chronic or severe SSTI include septic arthritis, septicaemia, 
osteomyelitis, endocarditis and AA amyloidosis (del Giudice, 2004; Harris et al., 2018). High 
levels of hospital admissions as a result of SSTI complications place an unnecessary burden 
on health care services;  estimates of costs to the NHS are in the region of £77 million per 
annum (Marks et al., 2013).  
 
Given the significant and increasing personal and healthcare burden of injecting-related 
SSTI, there is urgent need to develop acceptable, accessible and effective preventative 
interventions. Understanding the factors associated with SSTI among PWID in the UK is 
crucial to inform understanding of the rise in infections and implement effective 
interventions. Factors associated with SSTI are geographically variable, given geographical 
differences in drug form, type, preparation and administration practices (Ciccarone et al., 
2016; Ciccarone and Harris, 2015; Public Health England, 2019b). Although previous studies 
have examined the risks and associations with SSTI, using a range of time frames and 
measures, none have compared data from surveys which, when analysed together, provide 
both wide geographical coverage and in-depth examination of SSTI. In this analysis we 
combine data from two separate studies; one an in-depth survey exploring injecting practices 
and other factors associated with SSTI among PWID in London and the other, a larger bio-
behavioural surveillance study of infections and harms among PWID across England, Wales 
and Northern Ireland. Our analysis was undertaken primarily to assess the generalisability of 
the in-depth survey findings to the wider population of PWID, but also to explore the 
similarities and differences in the factors associated with SSTI among PWID when their 
occurrence is measured over different times frames (lifetime and recently) so as to improve 
our understanding of the key associations. Considering the multiple recent outbreaks of SSTI 
in PWID mentioned above, our integrated analysis of both datasets is timely; facilitating an 
in-depth exploration of factors associated with SSTI and their prevalence to inform 







2. MATERIALS & METHODS 
2.1 Study Sample Recruitment and Eligibility 
Anonymised data from two distinct surveys were used; 1) The Unlinked Anonymous 
Monitoring (UAM) Survey of PWID and 2) The Care and Prevent Study (‘Promoting skin 
and soft tissue infection care and preventing AA amyloidosis renal failure among people who 
inject drugs in the United Kingdom: a mixed-methods multi-phase study’). Methodological 
details for both have been previously published (Harris et al., 2018; V. Hope et al., 2014; 
Public Health England, 2019c).  
 
The UAM survey recruits PWID through a reflective sentinel sample of specialist services for 
PWID, such as needle/syringe programmes or addiction treatment centres (these services are 
widely provided throughout the UK), throughout England, Wales and Northern Ireland. 
Service users aged 18 and older, who have ever injected drugs, are eligible to participate 
annually in this surveillance study and those who agree to take part are offered an 
acknowledgement as well as a £4 voucher in compensation (£5 within London). Participants 
provide a dried-blood spot sample, which is tested for antibodies against HIV, hepatitis B and 
hepatitis C (HCV), and for HCV RNA, and self-complete a short questionnaire which 
includes a single question on the symptoms of an SSTI (a swelling containing pus (abscess), 
sore or open wound) at an injecting site in the previous year. The UAM survey has approval 
from Public Health England and the London Research Ethics Committee (98/2/051). 
Analysis was limited to data from the 2017 and 2018 surveys for respondents who reported 
injecting during the past year and who had answered questions on SSTI symptoms (n=2,874). 
Those who had not injected in the past year, and those who took part in 2018 who had 
already participated in the survey in 2017 were excluded (i.e. duplicates were excluded by 
only including the first participation in the two-year period, with repeats identified through 
reported year of last participation).  
 
Survey data from the Care and Prevent (C&P) Study, which recruited participants from drug 
treatment centres, homeless hostels and outreach services across London, were used. People 
were eligible to participate in the survey if they had ever injected psychoactive drugs, were 
aged 18 and over, and were assessed as able to provide informed consent. Those who agreed 
to participate completed a detailed researcher-administered, computer-assisted survey 
focused on SSTI and provided a urine sample for proteinuria urinalysis. Ethical approvals 




LSHTM Observational Research Ethics Committee [12021]. Survey participants received a 
£10 voucher as reimbursement for their time. In total, 455 PWID completed the survey 
between October 2017 and March 2019. Participants were asked to identify if they had ever 
had a SSTI and were provided with photographs of mild, moderate and severe abscesses, 
cellulitis and leg ulcers to aid their recall, ensure correct SSTI identification and provide a 
comparative measure to assess SSTI severity. In addition, participants were asked to self-
report whether they had ever been diagnosed with HCV. Both surveys collected similar or 
identical data on drug-use, injecting practices, sociodemographic characteristics and 
healthcare use. As the C&P survey asked about lifetime prevalence of SSTI, data analysis 
was not restricted to those who reported injecting in the previous year and included the entire 
sample of PWID.  
 
The possibility of someone participating in both studies is very low due to very limited 
overlap in the locations used for recruitment recruited. The majority (87%) of UAM survey 
recruitment sites were located outside of London, whereas all C&P recruitment sites were 
located in London. Although both surveys recruited participants in London, recruitment sites 
were focused in different areas and utilised different services.  
 
2.2 Analytical Methods  
Demographic and background characteristics of both samples were compared using 
descriptive statistics. Both univariable and multivariable logistic regression models were used 
to investigate the crude and adjusted associations of demographic variables and factors 
associated with SSTI, respectively. We present estimates of odds ratios (OR), 95% 
confidence intervals and tests of significance for each variable of interest. Multivariable 
regression models were built using a manual forward stepwise selection process to build 
separate models for each dataset to identify the factors associated with reporting SSTI. As 
opposed to a single combined model, two separate models were built to allow for flexibility 
and variability of different correlates in each dataset. Shortlisting for inclusion in the 
multivariable models was dependent on where there was evidence of an independent 
association with the outcome (LRT p-value ≤0.05 in the UAM survey and ≤0.1 in the C&P 
survey) and/or a suggested confounding effect from the minimally adjusted models. Since a 
test for confounding does not exist, an arbitrary ≥10% difference in adjusted ORs was used as 
the definition of confounding in these analyses. All shortlisted variables were iteratively 




variable’s impact on the crude OR of all other factors already built into the model was 
assessed to identify confounding. Likelihood Ratio Tests (LRTs) were also performed to 
assess the variable’s contribution to the model as an independent risk factor. At each forward 
step, retention in the model was dependent on the factor having the largest confounding effect 
or strongest evidence of being an independent risk factor. Assessment for multicollinearity in 
both models was performed through the comparison of the standard errors (SEs) of 
coefficients on the log scale to those of the unadjusted models. Variables which showed an 
increase of >10% were further investigated and individually removed to assess the nature of 
collinearity. Provided there was no a priori reason for its inclusion, identified collinearity 
between pairs was controlled for by removing the variables with the least confounding effect 
and the greatest change in SE from the model.  
 
3. RESULTS  
The characteristics of both samples were broadly similar. Both populations were skewed with 
respect to age, with 68% and 57% of participants aged 35 years or more in the UAM survey 
and the C&P survey, respectively, and more than two-thirds of participants identified as male 
in both studies (71% in UAM and 75% in C&P). Homelessness was common in both 
samples, with 78% of the C&P study sample reporting a history of street homelessness and 
50% of participants from the UAM survey reporting homelessness (both street and hostels) in 
the past year. Testing of DBS samples collected in the UAM survey found 27% had 
previously been infected with HCV (antibody positive and RNA negative) and 29% were 
currently infected with HCV (antibody and RNA positive). Higher prevalence of HIV was 
found in UAM participants recruited in London (6.4%) than in the overall sample (1.3%). In 
C&P, 54% of participants self-reported a previous HCV diagnosis and 5.7% reported a HIV 
diagnosis, corresponding to higher HIV prevalence in London found in UAM participants.  
 
SSTI prevalence was high in both samples; 52% of UAM participants reported having a SSTI 
symptom in the previous year and 65% of C&P participants reported an SSTI during their 
lifetime. In relation to the photographs provided, 33% of the C&P participants described their 
worst SSTI as mild, 41% as moderate and 26% as severe. In both studies, SSTI were least 
often reported in those who had been injecting for less than one year (29% and 28% in UAM 
and C&P, respectively), and they were most commonly reported among those who had made 
four or more attempts (needle insertions) to achieve a successful injection (66% for UAM, 





Univariable analyses uncovered similar factors associated with SSTI in both surveys. 
Participants who were aged 35+ years; had a current or previous HCV infection; reported 
injecting for three or more years; injected heroin or heroin and crack cocaine in combination; 
injected into their hands, feet, neck, groin or other body sites other than their arms or legs; 
and made more than one attempt at achieving an injection (UAM: last injection, C&P: typical 
injection), had increased odds of reporting SSTI (Table 1/Table 2).  
 
Following adjustment for potential confounding, we found the following factors were 
associated with increased odds of reporting SSTI or symptoms of SSTI in both samples: older 
age; injecting for three or more years; injecting into the hands, feet, neck, groin or other body 
sites other than their arms or legs; and making more than one attempt at achieving an 
injection. Sharing of needle/syringes was associated in UAM and reuse of needle/syringes in 
the C&P; these practices have been shown to be closely associated (V Hope et al., 2014) and 
these two measures of equipment reuse both reflect constrained access to sterile needles and 
syringes. Additional variables were also associated with increased SSTI but were not 
common to both samples; i.e. having overdosed in the past year; increased number of days 
injecting in the past month; and receiving income through social welfare, or illicit activities 
(Table 3). Two variables common to both were associated in one survey but not the other. 
Main drug injected in past year was associated with SSTI in the UAM, but not significant in 
C&P, probably due to the lower power of the C&P study. The other was HCV status which 
was associated in C&P but not the UAM. This is likely to relate to this variable being 
measured differently, using self-reports of HCV diagnosis in C&P and laboratory assessment 
in UAM. There was no evidence of multicollinearity found during our analyses.  
 
Table 1. Distribution of  associated factors  and Crude Odds Ratios for SSTIs: UAM Survey, England, Wales and 
Northern Ireland, 2017-2018  




OR 95% CI P-
value  
Total 2,874  1,486 (52) - - - 
























































Hepatitis C Test Result  
Negative (antibody negative) 
Current Infection (antibody and RNA positive) 
Past Infection (antibody positive, RNA negative) 























HIV Test Result 
Negative 
































Taken Part in Transactional Sex  
Never 
Yes, but not in past year 



















Homeless (Street or Hostels) 
No 
Yes, but not in past year 




































Drug Injection and Preparation 























Main drug Injected in past year  



















































Injecting Frequency, Sites and Hygiene 




























Body Sites injected in past month 
Arms or Legs only  
Hands or Feet 































































Abbreviations: N= number of individuals; OR= odds ratio; CI= confidence interval; Ref= reference group;  
Note: Those who reported injecting into their hands or feet could also have injected into their arms or legs and those who 










Table 2. Distribution of  associated factors  and Crude Odds Ratios for SSTIs: Care and Prevent Study, London, 2018-2019 
Variables of Interest N  Ever SSTIs (%) 
 
OR 95% CI P-value  
Total 455  296 (65.0) - - - 















































































































Main Income Source  
Regular/Temporary Job/Family Support 
















Drug Injection and Preparation  
Years injecting  






















Main Drugs Injected in past year  

















Ever Re-use Filters 
No, Never/Yes, Occasionally  

































Injecting Frequency, Sites and Hygiene 
Typical Injecting Frequency  
Once per week 
2-7 times per week 



















Most common Body Site Injected in past year  
Arms or Legs  
Hands or Feet 

















































































Always 134  83 (62) Ref. - 








































Abbreviations: N= number of individuals; OR= odds ratio; CI= confidence interval; Ref= reference group. 
Table 3: Adjusted Odds Ratios of associated factors for SSTIs: Both Datasets  
 UAM Survey  Care & Prevent Study  
Variables in Multivariable Model  AOR (95% CI) LRT AOR (95% CI) LRT 







































































Main Income Source  
Regular Job/Temporary Work/Family Support 











Drug Injection and Preparation Variables 
























Main Drug Injected in past year  
Amphetamine-like  












Injecting Frequency, Sites and Hygiene Variables 
Main Injection Site on Body in past year  
Arms or Legs 
Hands or Feet 



















































































Both samples found high prevalence of self-reported SSTI with commonalities in associated 
factors that indicate that SSTIs are related with venous access issues as well as hygiene. 
Lifetime prevalence estimates of SSTI from the C&P study (65%) were higher than those in 
Australia (27%) and Mexico (46%) (Buchanan, 2006; Topp, 2008), but similar to the levels 
reported in the USA (68%) and Ireland (69%) (Biswanger, 2000; Maloney, 2010). UAM 
reported prevalence of SSTI in the previous year (52%) was higher than comparable studies, 
with 37% the highest reported (to our knowledge) in a sample of 864 PWID from the 
California, USA (Fink et al., 2013). Multivariable analyses illustrate common associations 
with SSTI in both surveys: older age; number of years injecting; injecting into the neck 
and/or groin; making more than one attempt to achieve an injection. And markers of 
constrained needle and syringe supply (i.e. sharing or reuse).  
The association with markers of constrained needle and syringe supply, that is sharing in 
UAM Survey and reuse in C&P, highlights the need to improve the provision of needle and 
syringe programmes (NSPs) in the UK. New sterile injection equipment, and access to other 
materials such as clean water and swabs, are key to maintain hygienic injection practice, and 
so to reduce incidence of SSTI (Harris et al., 2020). While NSPs are widely provided 
throughout the UK, their provision over the last decade has been impacted by austerity with 
this increasingly focused on community pharmacies with fewer specialist services (Britsh 
Medical Association, 2018; Local Government Association, 2018). Our data indicates 
coverage is currently insufficient, and there is also probably inequity in access (Public Health 
England, 2019d); NSP provision urgently needs to be improved. 
Age and length of time injecting are highly correlated with each other (Dwyer et al., 2009; 
Fink et al., 2013; Hope et al., 2008; Tempalski et al., 2013). The association of SSTI 
occurrence with age is therefore likely to reflect the impact of long-term injecting and in 









 Variable was not asked in the survey.  Variable was asked but was not significant in the final model. Abbreviations:
N= number of individuals; AOR= adjusted odds ratio; CI= confidence interval; LRT= likelihood ratio test p value; Ref=
reference group. Note: In the UAM study, questions based on practices in the past month included a level with those
who did not inject in the past month in order to retain the full set of observations for multivariable analysis.
12 
particular, the hardening/narrowing of veins (venous sclerosis), which often occurs after 
injecting for many years (Maliphant and Scott, 2005). Difficulty injecting into sclerotic veins 
can lead to unintentional subcutaneous injection (or ‘missed hits’) (Rhodes et al., 2007) and 
require an increased number of attempts to achieve an injection. Difficulty accessing 
peripheral veins also precipitates transitions to more risky injection sites, such as the femoral 
vein in the groin or the jugular vein in the neck (Ciccarone and Harris, 2015; Darke et al., 
2001). In both samples, a high proportion of participants reported injecting into the femoral 
or jugular vein in the past year (UAM: 45%; C&P: 55%) and making four or more attempts 
before achieving an injection (UAM; 22%, C&P: 24%). As reported in previous studies, our 
analysis produced strong multivariable associations between SSTI, multiple injection 
attempts and injecting in the femoral or jugular vein (Harris and Rhodes, 2012; Hope et al., 
2017). It is also possible that there is an element of reverse causality at play, as transitioning 
to these other body sites and higher numbers of missed injections may be a result of SSTI 
already present in the arms or legs.  
In both samples, and in accordance with the literature, women more often reported an SSTI 
than men, however, due to limited power, the association was not significant in the C&P 
sample and was thus not listed as an association found in both surveys (Fink et al., 2013; 
Hope et al., 2008; Lloyd-Smith et al., 2005; Spijkerman et al., 1996). Increased susceptibility 
to risk is likely due to an interplay of physical and social factors. Women may experience 
loss of peripheral venous viability earlier in their injecting trajectory than men, due to a finer 
venous structure (Huxley, 2007). Difficult venous access, as previously stated, can precipitate 
unintentional and intentional subcutaneous injection as well as transitions to deeper veins, 
such as the jugular and femoral veins, injection into which carries a greater infection risk 
(Lloyd-Smith, 2009; Topp, 2008). Women are particularly vulnerable to adverse 
consequences of identification as a person who injects drugs (such as loss of children, family 
support and/or sex-work income) and may transition early to injecting into less visible sites 
such as the groin (Harris and Rhodes, 2013). Gendered power dynamics can exacerbate risk 
of unsafe injecting, with women more likely than men to have limited control over drug 
purchase, injection equipment supply, drug injection preparation or administration (Hope et 
al., 2010; Morris et al., 2018). This can increase the likelihood of receiving injecting 
assistance and using injecting equipment after others (Wood, 2003). Sex work is more likely 
to be a viable income-generation avenue for women who inject drugs. Sex work among 




However, as sex work may be undertaken to financially support high levels of injecting 
(Morris et al., 2018) it is spurious to imply a causal link.  
 
The majority of participants in both samples report injecting heroin or a heroin/crack cocaine 
combination. Amphetamine or sole injection of powder cocaine was relatively rare. 
Preparation of heroin and/or crack cocaine for injection in the UK, requires use of an acidifier 
with water to render these base drugs into an injectable solution. The C&P study has 
previously shown that overuse of an acidifier for injection was common, with 30% using a 
whole sachet of acid or more (Harris et al., 2019). There is a likely causal pathway between 
acidifier overuse and venous damage, which in turn precipitates SSTI risk (Ciccarone and 
Harris, 2015; Harris et al., 2019). Amphetamine-like drugs, with limited SSTI risk, are water-
soluble and do not need to be prepared using an acid (Ciccarone, 2011) .  
 
The substantial similarity of the associations with factors related to venous damage in both 
samples, such as numerous repeat injection attempts, reinforced the significance of these 
factors in influencing SSTI development and the need for interventions addressing venous 
health (Harris et al., 2019). High comparability of associations in both samples strengthen 
their generalizability across the UK and so our confidence in understanding the factors 
associated with SSTI that impact PWID.  
 
The association between SSTI and repeat injection attempts – something that may be easy for 
services to ask about – suggests a possible avenue for identification of those with vascular 
access problems and/or poor injection technique for the offer of interventions. Interventions 
offered should address, besides general injection hygiene, the importance of vein health and 
include advice to improve this, e.g. to reduce acid use, rotate injection sites, and 
recommendations to reduce the number of injection attempts.  
 
4.1 Limitations  
Although the sample size of the UAM Survey was larger than C&P, both were adequately 
powered. However, the smaller C&P study sample and the differences in a number of the 
questions asked prevented a combined analysis approach. Both data sources may be subject 
to reporting bias as self- reports of SSTI symptoms were used, although this was minimised 
in the C&P study, which used photos of typical symptoms in the survey. However, previous 




(Morrison et al., 1997). As we used data from cross-sectional studies, we were not able to 
investigate temporal relationships between factors associated with and SSTI and indeed we 
could not eliminate the possibility of reverse causality. Systemic differences in questions 
asked between surveys limited interpretation and thus require caution when being compared. 
Finally, we cannot exclude the possibility of participant duplication between both studies, 
although, as addressed in the methods, this is unlikely.  
 
4.2 Conclusion  
The results of this study highlight a high prevalence of SSTI amongst PWID in the UK. 
Injecting- related SSTI are largely preventable, yet are a significant burden, both in terms of 
the suffering experienced by PWID and economic and health system costs. Together, our two 
datasets provide strong evidence of an association between difficulties with venous access 
and SSTI occurrence and reiterate the importance of providing easy access to the materials 
needed for hygienic injection. A high proportion of respondents in both samples required 
multiple attempts to achieve an injection and transitions to injecting in deep veins, such as the 
femoral, were also common. There is a clear need to attend to the underlying causes of 
venous damage among PWID in the UK. As detailed elsewhere (Harris et al., 2019) overuse 
of acidifiers is a potentially modifiable risk factor. Asking about repeat injection attempts 
may be an easy to use approach for health services to identify those with vascular access 
problems and/or poor injection technique and so offer targeted interventions. Interventions 
should address, besides general injection hygiene, the importance of vein health, including 
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